港股異動 | 影視股走強 五一檔預售票房破5400萬
格隆匯4月27日丨影視股走強,華夏視聽教育漲超4%,貓眼娛樂漲超3%,阿里影業漲超1%。燈塔專業版實時數據顯示,截至昨日18時30分,五一檔新片預售總票房超5400萬。《你的婚禮》超2200萬暫時領跑,《懸崖之上》以1716萬元排在第二,《祕密訪客》位列第三。中金指出,後疫情時代電影票房檔期效應明顯,五一檔作為小檔期亦有較高關注度。五一檔或幫助全年票房穩步增長。據預計,中性情形下2021年五一檔含服務費票房為17億元,較2019年增長11.6%。中原證券亦認為,清明節後電影市場暫時冷卻,但自4月30日開始將有多部影片集中上映,疊加5天假期,預計5月會有較好的表現。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.